TB-500 identification research distinguishes an acetylated peptide fragment from full-length thymosin beta-4.
In simple words
TB-500 is a name used for a peptide fragment associated with thymosin beta-4. The selected identification study examined N-acetylated LKKTETQ, not the full-length protein; the catalogue name alone does not confirm the vial’s sequence.
The reviewed TB-500 study identified N-acetylated LKKTETQ. The catalogue name alone does not confirm that sequence; full-length thymosin beta-4 is different.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about TB-500
What is TB-500?
TB-500 is a name used for a peptide fragment associated with thymosin beta-4. The selected identification study examined N-acetylated LKKTETQ, not the full-length protein; the catalogue name alone does not confirm the vial’s sequence.
What types of research are cited for TB-500?
The TB-500 profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
TB-500 identity and equine detection (2012): Analytical — laboratory and horses
The reviewed TB-500 study identified N-acetylated LKKTETQ. The catalogue name alone does not confirm that sequence; full-length thymosin beta-4 is different.
What do the selected TB-500 studies not establish?
TB-500 identity and equine detection (2012): This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
These studies do not establish the identity, purity, safety or effects of the MXC TB-500 vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.